V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260019358 | 260008896 | 1.74 | 83.8 | Curative (C) | 2018-02-20 | 2018-03-16 | null | N | N | 260026754 | NOT MATCHED |
| 260019359 | 260009148 | 1.77 | 79 | Disease modification (D) | 2016-08-15 | 2017-03-10 | null | N | N | 260027222 | NOT MATCHED |
| 260019360 | 260009305 | 1.89 | null | Curative (C) | 2015-11-18 | 2015-11-25 | BEAM | 02 | N | 260027954 | LEAM |
| 260019361 | 260009389 | 0 | 85.4 | Curative (C) | 2019-08-11 | 2019-08-21 | Trial Unspecified | 2 | N | 260028301 | TRIAL |
| 260019362 | 260009435 | 1.83 | null | Curative (C) | 2018-06-01 | 2018-06-03 | Dacarbazine | 2 | N | 260028436 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260019363 | 260009540 | 1.72 | 63 | Curative (C) | 2016-04-09 | 2016-04-12 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260028790 | VIP |
| 260019364 | 260009549 | 1.81 | 82.2 | Neo-adjuvant (N) | 2015-12-11 | 2015-12-11 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | N | 260028814 | CYTARABINE + METHOTREXATE HD |
| 260019365 | 260009598 | 1.84 | 61.4 | Curative (C) | 2019-11-04 | 2019-11-04 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE | 2 | N | 260028993 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE |
| 260019366 | 260009666 | 1.54 | null | Curative (C) | 2019-08-07 | 2019-08-07 | ICE | N | N | 260029207 | CHOP |
| 260019367 | 260009728 | 1.7 | 90 | Curative (C) | 2017-09-23 | 2017-09-23 | BLEOMYCIN | 2 | N | 260029421 | VIP |
| 260019368 | 260009772 | 1.6 | 66 | Curative (C) | 2020-03-02 | 2020-04-24 | Carboplatin + Etoposide IV 3 day | 02 | N | 260029532 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260019369 | 260010104 | 1.81 | 60 | Curative (C) | 2018-06-27 | 2018-07-11 | ICE + GCSF | N | N | 260012314 | CISPLATIN |
| 260019370 | 260019265 | 1.74 | 101.4 | Disease modification (D) | 2017-02-08 | 2017-02-13 | EP | 02 | N | 260014167 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260019371 | 260010188 | 1.87 | 66 | Curative (C) | 2018-11-29 | 2018-11-30 | EP | 2 | N | 260021633 | IFOSFAMIDE + PACLITAXEL |
| 260019372 | 260010220 | 1.82 | 129.6 | Curative (C) | 2017-06-05 | 2017-06-05 | BLEOMYCIN + VINCRISTINE | 02 | N | 260006709 | BLEOMYCIN |
| 260019373 | 260006922 | 1.73 | 100.4 | Palliative (P) | 2019-03-17 | 2019-03-20 | Rituximab | null | null | 260019353 | RITUXIMAB |
| 260019374 | 260013352 | 176 | 0 | Palliative (P) | 2016-10-06 | 2017-07-04 | Rituximab (Maintenance) | Y | N | 260022340 | RITUXIMAB |
| 260019375 | 260013848 | null | 0 | Palliative (P) | 2020-04-01 | 2020-04-01 | Rituximab | 02 | N | 260025413 | RITUXIMAB |
| 260019376 | 260014054 | 1.54 | 98.45 | Palliative (P) | 2018-07-02 | 2018-07-24 | Rituximab | N | N | 260026185 | RITUXIMAB |
| 260019377 | 260008775 | 0 | null | Palliative (P) | 2017-10-27 | 2017-10-27 | Rituximab | 2 | N | 260026547 | RITUXIMAB |
| 260019378 | 260014181 | 1.55 | null | Palliative (P) | 2017-06-22 | 2017-08-25 | Bendamustine+Rituximab(Sub Courses) | null | null | 260026596 | BENDAMUSTINE + RITUXIMAB |
| 260019379 | 260008863 | 1.93 | 73.2 | Curative (C) | 2019-05-18 | 2019-05-25 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260026703 | BENDAMUSTINE + RITUXIMAB |
| 260019380 | 260008873 | 1.74 | 54.6 | Palliative (P) | 2015-07-08 | 2015-08-08 | CHOP R - 21 days | N | null | 260026713 | CHOP R |
| 260019381 | 260008887 | 1.87 | 80.9 | Disease modification (D) | 2018-09-30 | 2018-11-19 | Trial Unspecified | N | N | 260026742 | TRIAL |
| 260019382 | 260009149 | 1.78 | 95 | Curative (C) | 2017-09-25 | 2017-10-12 | ICE-R | N | N | 260027222 | ICE-R |
| 260019383 | 260009390 | 1.7 | 63.5 | Curative (C) | null | 2019-12-14 | BLEOMYCIN | N | N | 260028301 | BLEOMYCIN |
| 260019384 | 260009541 | null | 64 | Disease modification (D) | 2015-11-12 | 2016-04-12 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260028790 | EP |
| 260019385 | 260009549 | null | 88 | Disease modification (D) | 2019-07-13 | 2019-07-23 | Vinblastine weekly | 2 | N | 260028814 | IFOSFAMIDE + PACLITAXEL |
| 260019386 | 260009772 | 1.62 | 66 | Curative (C) | 2020-04-24 | 2020-04-24 | BLEOMYCIN + VINCRISTINE | N | N | 260029532 | TRASTUZUMAB |
| 260019387 | 260010104 | 1.77 | 75 | Curative (C) | 2018-07-21 | 2018-09-06 | IVADo | N | N | 260012314 | EP |
| 260019388 | 260014822 | null | 65 | Curative (C) | 2019-02-01 | 2019-02-01 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL | 02 | N | 260021633 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260019389 | 260006923 | 1.73 | 86.9 | Palliative (P) | 2019-08-17 | 2019-09-14 | Rituximab (SUBCUTANEOUS Maintenance) | null | null | 260019353 | RITUXIMAB |
| 260019390 | 260016715 | 1.54 | null | Curative (C) | 2018-07-24 | 2018-07-24 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260026185 | RITUXIMAB |
| 260019391 | 260008775 | 0 | null | Palliative (P) | 2018-03-15 | 2018-03-15 | Rituximab | 2 | null | 260026547 | RITUXIMAB |
| 260019392 | 260016777 | 0 | 97.4 | null | 2016-10-13 | 2018-02-11 | Rituximab | N | null | 260026596 | RITUXIMAB |
| 260019393 | 260008888 | 1.77 | 73 | Curative (C) | 2018-05-02 | 2018-11-19 | Rituximab (Maintenance) | N | N | 260026742 | RITUXIMAB |
| 260019394 | 260009542 | 1.74 | null | Disease modification (D) | 2015-10-19 | 2016-04-12 | PACIFICO TRIAL | 02 | N | 260028790 | PACIFICO TRIAL |
| 260019395 | 260010104 | null | 89.7 | Curative (C) | 2018-09-03 | 2018-09-06 | CHOP - 21 days | 02 | N | 260012314 | CHOP |
| 260019396 | 260014822 | null | 71.2 | Curative (C) | 2019-08-02 | 2019-08-06 | BLEOMYCIN | 02 | N | 260021633 | GEMCITABINE + TIP |
| 260019397 | 260014226 | 1.77 | 102 | Palliative (P) | 2018-10-06 | 2019-05-06 | Rituximab | N | N | 260026742 | RITUXIMAB |
| 260019398 | 260014543 | null | null | Disease modification (D) | 2016-01-05 | 2016-05-03 | R GCVP | 2 | N | 260028790 | CVP R |
| 260019399 | 260010104 | null | 82 | Curative (C) | 2019-02-12 | 2019-02-12 | STS Rhabdomyosarcoma RMS 2005 IVA | 2 | N | 260012314 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260019400 | 260016961 | 1.58 | 63 | Disease modification (D) | 2016-05-19 | 2016-06-28 | Rituximab (INTRAVENOUS Maintenance) | 2 | N | 260028790 | RITUXIMAB |
| 270000001 | 270000001 | 1.78 | 69 | Not known (9) | 2013-05-16 | 2013-05-22 | ABVD | N | N | 270000005 | ABVD |
| 270000002 | 270010939 | 1.83 | 70.4 | Curative (C) | 2014-03-07 | 2014-03-11 | ABVD | 2 | N | 270000008 | ABVD |
| 270000003 | 270015096 | 0 | 81 | Curative (C) | 2013-05-18 | 2013-06-01 | ABVD | N | N | 270000009 | ABVD |
| 270000004 | 270015096 | 1.76 | 91 | Curative (C) | 2017-08-31 | 2017-09-06 | ABVD | 2 | null | 270000009 | ABVD |
| 270000005 | 270015096 | 1.88 | 83.4 | Curative (C) | 2015-09-14 | 2015-10-09 | ABVD | N | N | 270000009 | ABVD |
| 270000006 | 270015096 | null | 73.6 | null | 2017-12-03 | 2017-12-03 | ABVD | N | N | 270000009 | ABVD |
| 270000007 | 270015096 | 1.82 | 67 | Curative (C) | 2014-07-11 | 2014-07-22 | ABVD | N | N | 270000009 | ABVD |